Preliminary results of active specific immunization with modified tumor cell vaccine in glioblastoma multiforme

Newcastle disease virus (NDV): brief history of its oncolytic strains

Use of Newcastle disease virus vaccine (MTH-68/H) in a patient with high-grade glioblastoma

Tumor stimulator cell modification by infection with Newcastle Disease Virus: analysis of effects and mechanism in MLTC-CML cultures

Human tumor cell modification by virus infection: an efficient and safe way to produce cancer vaccine with pleiotropic immune stimulatory properties when using Newcastle disease virus

A 15-year follow-up of AJCC stage III malignant melanoma patients treated postsurgically with Newcastle disease virus (NDV) oncolysate and determination of alterations in the CD8 T cell repertoire

Introduction of adhesive and costimulatory immune functions into tumor cells by infection with Newcastle Disease Virus

Tumor-cell number and viability as quality and efficacy parameters of autologous virus-modified cancer vaccines in patients with breast or ovarian cancer

Complete regression of human fibrosarcoma xenografts after local Newcastle disease virus therapy

A ten-year follow-up on stage II malignant melanoma patients treated postsurgically with Newcastle disease virus oncolysate